Host risk factors, ultraviolet index of residence, and incident malignant melanoma in situ among US women and men

American Journal of Epidemiology

Volumn 177, Issue 9, 2013, Pages 997-1005

  Walls, Andrew C ^a   Han, Jiali ^a,b   Li, Tricia ^a   Qureshi, Abrar A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hutchinson's melanotic freckle; melanoma; nevus; sunburn; ultraviolet rays

Indexed keywords

DATA ACQUISITION; DISEASE INCIDENCE; HEALTH MONITORING; HEALTH RISK; PHENOTYPE; ULTRAVIOLET RADIATION;

ADULT; ARTICLE; CANCER RISK; COHORT ANALYSIS; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; FOLLOW UP; HAIR COLOR; HUMAN; MALE; MALIGNANT MELANOMA IN SITU; MELANOMA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHENOTYPE; PROSPECTIVE STUDY; STRUCTURED QUESTIONNAIRE; SUNBURN; ULTRAVIOLET INDEX OF STATE OF RESIDENCE AT BIRTH; UNITED STATES;

HUTCHINSON'S MELANOTIC FRECKLE; MELANOMA; NEVUS; SUNBURN; ULTRAVIOLET RAYS;

ADULT; AGED; FEMALE; HAIR COLOR; HUMANS; INCIDENCE; MALE; MELANOMA; META-ANALYSIS AS TOPIC; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEVUS; PHENOTYPE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; RISK FACTORS; SKIN PHYSIOLOGICAL PHENOMENA; SUNBURN; ULTRAVIOLET RAYS; UNITED STATES;

UNITED STATES;

EID: 84877252838     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws335     Document Type: Article

References (43)

1. Lee JA. The systematic relationship between melanomas diagnosed in situ and when invasive. Melanoma Res. 2001; 11(5):523-529.
2. Linos E, Swetter SM, Cockburn MG, et al. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009;129(7):1666-1674.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29.
4. Ulmer MJ, Tonita JM, Hull PR. Trends in invasive cutaneous melanoma in Saskatchewan 1970-1999. J Cutan Med Surg. 2003;7(6):433-442.
5. Wassberg C, Thorn M, Yuen J, et al. Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ. Int J Cancer. 1999;83(3):314-317.
6. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst. 2001;93(11):824-842.
7. MacKie RM, Bray CA, Hole DJ, et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet. 2002;360(9333):587-591.
8. Vilar-Coromina N, Vilardell L, Cano A, et al. Rapid increase in incidence of melanoma in situ in Girona (Spain), 1994-2005. Effectiveness of public education campaigns about early diagnosis [in Spanish]. Actas Dermosifiliogr. 2010;101(6): 561-563.
9. Nielsen K, Masback A, Olsson H, et al. A prospective, population-based study of 40, 000 women regarding host factors, UV exposure and sunbed use in relation to risk and anatomic site of cutaneous melanoma. Int J Cancer. 2012; 131(3):706-715.
10. Mocellin S, Nitti D. Cutaneous melanoma in situ: translational evidence from a large population-based study. Oncologist. 2011;16(6):896-903.
11. Thorn M, Ponten F, Johansson AM, et al. Rapid increase in diagnosis of cutaneous melanoma in situ in Sweden, 1968-1992. Cancer Detect Prev. 1998;22(5):430-437.
12. Swetter SM, Boldrick JC, Jung SY, et al. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol. 2005; 125(4):685-691.
13. Coory M, Baade P, Aitken J, et al. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control. 2006;17(1):21-27.
14. Criscione VD, Weinstock MA. Melanoma thickness trends in the United States, 1988-2006. J Invest Dermatol. 2010; 130(3):793-797.
15. Bentham G, Aase A. Incidence of malignant melanoma of the skin in Norway, 1955-1989: associations with solar ultraviolet radiation, income and holidays abroad. Int J Epidemiol. 1996;25(6):1132-1138.
16. Geller AC, Swetter SM, Brooks K, et al. Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol. 2007; 57(4):555-576.
17. Welch HG, Woloshin S, Schwartz LM. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ. 2005;331(7515):481.
18. Mihm MC Jr., Clark WH Jr., From L. The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N Engl J Med. 1971; 284(19):1078-1082.
19. Greene VR, Johnson MM, Grimm EA, et al. Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma. J Invest Dermatol. 2009;129(6):1483-1488.
20. Girouard SD, Laga AC, Mihm MC, et al. SOX2 contributes to melanoma cell invasion. Lab Invest. 2012; 92(3):362-370.
21. Rosina P, Tessari G, Giordano MV, et al. Clinical and diagnostic features of in situ melanoma and superficial spreading melanoma: a hospital based study. J Eur Acad Dermatol Venereol. 2012;26(2):153-158.
22. Stricklin SM, Stoecker WV, Malters JM, et al. Melanoma in situ in a private practice setting 2005 through 2009: location, lesion size, lack of concern. J Am Acad Dermatol. 2012;67(3): e105-e109.
23. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199-6206.
24. Schneider JS, Moore DH II, Mendelsohn ML. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. J Am Acad Dermatol. 2008;58(5):741-749.
25. Sachdeva S. Fitzpatrick skin typing: applications in dermatology. Indian J Dermatol Venereol Leprol. 2009; 75(1):93-96.
26. United States Environmental Protection Agency. How UV index is calculated. Washington, DC: United States Environmental Protection Agency; 2012. (http://www.epa.gov/sunwise/uvicalc.html). (Accessed June 10, 2012).
27. Qureshi AA, Laden F, Colditz GA, et al. Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma. Arch Intern Med. 2008;168(5):501-507.
28. Kvaskoff M, Siskind V, Green AC. Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia. Arch Dermatol. 2012;148(2):164-170.
29. Siskind V, Hughes MC, Palmer JM, et al. Nevi, family history, and fair skin increase the risk of second primary melanoma. J Invest Dermatol. 2011;131(2):461-467.
30. Gaudy-Marqueste C, Madjlessi N, Guillot B, et al. Risk factors in elderly people for lentigo maligna compared with other melanomas: a double case-control study. Arch Dermatol. 2009;145(4):418-423.
31. Solomon CC, White E, Kristal AR, et al. Melanoma and lifetime UV radiation. Cancer Causes Control. 2004;15(9): 893-902.
32. Caini S, Gandini S, Sera F, et al. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer. 2009;45(17): 3054-3063.
33. Qureshi AA, Zhang M, Han J. Heterogeneity in host risk factors for incident melanoma and non-melanoma skin cancer in a cohort of US women. J Epidemiol. 2011;21(3):197-203.
34. Park SL, Le Marchand L, Wilkens LR, et al. Risk factors for malignant melanoma in white and non-white/non-African American populations: the multiethnic cohort. Cancer Prev Res (Phila). 2012;5(3):423-434.
35. Zalaudek I, Schmid K, Marghoob AA, et al. Frequency of dermoscopic nevus subtypes by age and body site: a cross-sectional study. Arch Dermatol. 2011;147(6):663-670.
36. Hemminki K, Zhang H, Czene K. Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites. Int J Cancer. 2003;104(6):764-771.
37. Coldiron BM. The UV index: a weather report for skin. Clin Dermatol. 1998;16(4):441-446.
38. Wei-Passanese EX, Han J, Lin W, et al. Geographical variation in residence and risk of multiple nonmelanoma skin cancers in US women and men. Photochem Photobiol. 2012;88(2): 483-489.
39. Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations-US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol. 2005;141(4): 477-481.
40. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41(1):45-60.
41. Dulon M, Weichenthal M, Blettner M, et al. Sun exposure and number of nevi in 5-to 6-year-old European children. J Clin Epidemiol. 2002;55(11):1075-1081.
42. Wiecker TS, Luther H, Buettner P, et al. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1, 812 Kindergarten children. Cancer. 2003;97(3): 628-638.
43. Aalborg J, Morelli JG, Mokrohisky ST, et al. Tanning and increased nevus development in very-light-skinned children without red hair. Arch Dermatol. 2009; 145(9):989-996.